Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer

Massimo Calafiore begins as President and Chief Government Officer, efficient instantly
Julie Andrews is appointed as Chief Monetary Officer, assuming the position efficient January 15, 2024

LEWISVILLE, Texas, January 8, 2024–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ: OFIX), a number one world spine and orthopedics firm, at the moment introduced that efficient instantly, Massimo Calafiore has assumed the position of President and Chief Government Officer (CEO) and as a member of the Orthofix Board of Administrators. At the side of Mr. Calafiore entering into his position as CEO, the Firm has introduced the appointment of Julie Andrews as Chief Monetary Officer. Ms. Andrews beforehand served as CFO for Sensible Wires Know-how, the place she led all finance, tax, treasury, accounting, info know-how, and investor relations capabilities. Previous to that position, Ms. Andrews served because the Senior Vice President, International Finance for Wright Medical Group, a worldwide medical system firm targeted on extremities and biologics that was acquired by Stryker in 2020, and earlier than that, she was the Vice President of Finance for the Backbone and Biologics division of Medtronic Inc.

“I’m thrilled to announce that Massimo has formally began in his position as President and CEO and am equally excited to welcome Julie to Orthofix as incoming CFO,” mentioned Catherine Burzik, Chair of the Board of Administrators and former Interim CEO of Orthofix. “Our seek for these important administration roles was executed rapidly and completely, with many extremely certified candidates expressing curiosity in main Orthofix. We’re assured we now have chosen two visionary executives who will carry significant views and experience to the Firm and that their management will serve us effectively within the years forward.”

Mr. Calafiore commented, “I’m honored to formally start this position at this necessary time for the Firm, and I’m excited to welcome Julie to the staff subsequent week. I sit up for working with the greater than 1,600 workers who dedicate themselves to furthering our mission to ship significant and life-improving applied sciences for our surgeon clients and their sufferers.”

About Massimo Calafiore

Mr. Calafiore joined LimaCorporate S.p.A., a worldwide orthopedics firm in September 2022, the place he served as CEO till the January 3, 2024, acquisition of LimaCorporate by Enovis Company (NYSE: ENOV). Previous to this he served as Government Vice President and Chief Business Officer of NuVasive, Inc. Throughout his tenure at NuVasive, Mr. Calafiore served as President of NuVasive Specialised Orthopedics (previously Ellipse Applied sciences). Earlier in his profession, Mr. Calafiore labored for Waldemar Hyperlink GmbH & Co. KG and served in varied management roles throughout a number of enterprise segments, together with orthopedics, decrease extremities, and spine.

He obtained his M.Sc. in Mechanical Engineering from the College of Catania and an MBA from New York College.

About Julie Andrews

Ms. Andrews joined Sensible Wires Know-how, a worldwide transmission grid know-how firm targeted on enabling the transition to renewable power, as CFO in 2021. From 2012 to 2020, she served as Senior Vice President, International Finance and Vice President, International FP&A, and Chief Accounting Officer at Wright Medical Group, the place Ms. Andrews led a 170-person finance staff. Previous to this, Ms. Andrews spent a few years in roles of accelerating duty at Medtronic Inc., together with as Vice President of Finance for the Backbone and Biologics division, the place she offered oversight of all FP&A and accounting capabilities. Early in her profession, Ms. Andrews served as a Senior Monetary Analyst for Thomas & Betts and as an auditor for Thomas Havey, LLC.

At present, she serves on the board of RxSight, Inc., an ophthalmic medical system firm. Ms. Andrews obtained a Bachelor of Science in Accounting from Indiana College. She additionally participated in superior chief and director growth packages at each Medtronic and Wharton College of Enterprise.

About Orthofix

Orthofix is a number one world spine and orthopedics firm with a complete portfolio of biologics, revolutionary spinal {hardware}, bone development therapies, specialised orthopedic options, and a number one surgical navigation system. Its merchandise are distributed in roughly 68 international locations worldwide.

The Firm is headquartered in Lewisville, Texas and has main workplaces in Carlsbad, CA, with a give attention to spine and biologics product innovation and surgeon schooling, and Verona, Italy, with an emphasis on product innovation, manufacturing, and medical schooling for orthopedics. The mixed Firm’s world R&D, industrial and manufacturing footprint additionally consists of services and workplaces in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Wayne, PA, Olive Department, MS, Maidenhead, UK, Munich, Germany, Paris, France and Sao Paulo, Brazil.

Ahead-Trying Statements

This information launch might embrace forward-looking statements throughout the which means of Part 21E of the Securities Change Act of 1934, as amended, and Part 27A of the Securities Act of 1933, as amended. In some circumstances, you’ll be able to establish forward-looking statements by terminology corresponding to “might,” “will,” “ought to,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “tasks,” “intends,” “predicts,” “potential,” “proceed” or different comparable terminology. Orthofix cautions you that statements included on this information launch that aren’t an outline of historic information are forward-looking statements which can be primarily based on the Firm’s present expectations and assumptions. Every forward-looking assertion contained on this information launch is topic to dangers and uncertainties that would trigger precise outcomes to vary materially from these expressed or implied by such assertion. Relevant dangers and uncertainties embrace, amongst others: the flexibility of newly launched merchandise to carry out as designed and meant and to satisfy the wants of surgeons and sufferers, together with because of the shortage of sturdy scientific validation; and the dangers recognized below the heading “Threat Elements” in Orthofix Medical Inc.’s Annual Report on Kind 10-Ok for the fiscal yr ended December 31, 2022, which was filed with the Securities and Change Fee (SEC) on March 6, 2023. The Firm’s public filings with the Securities and Change Fee can be found at www.sec.gov. You might be cautioned to not place undue reliance on forward-looking statements, which communicate solely as of the date when made. Orthofix doesn’t intend to revise or replace any forward-looking assertion set forth on this information launch to mirror occasions or circumstances arising after the date hereof, besides as could also be required by regulation.